Nature Study Finds Base Editing Leaves Mixed Cells in Early Human Embryos, Despite NANOG Insight
Updated
Updated · STAT · Jun 25
Nature Study Finds Base Editing Leaves Mixed Cells in Early Human Embryos, Despite NANOG Insight
3 articles · Updated · STAT · Jun 25
Summary
A Nature study found base editing in early human embryos produced mosaic results, with some cells edited and others unchanged even as embryos kept developing.
NANOG emerged as a key gene directing the earliest stages of human development: disabling it prevented normal embryo formation in donated eggs.
The work suggests next-generation editing is more precise and less damaging than older CRISPR methods, raising the possibility of future clinical use to fix disease-causing mutations.
That prospect also sharpens the ethical fight over embryo editing, because the same tools could be used not just for disease prevention but potentially for trait selection or enhancement.
This new gene editing is safer, so why do experts still warn it's a "disastrous" idea for reproduction?
"Designer babies" are closer than ever. Who decides which human traits are flaws to be erased?
Base Editing Advances in Human Embryos: Scientific Progress, Ethical Dilemmas, and Regulatory Gaps
Overview
A major breakthrough in gene editing was achieved in June 2026 by Dr. Dieter Egli and his team at Columbia University, working with Nucleus Genomics. Their new base editing technique for embryo editing is seen as a big step forward, offering much greater precision than older CRISPR-Cas9 methods. This innovation helps solve problems like chromosome loss and genome instability that were common with previous approaches. The improved accuracy brings scientists closer to curing inherited diseases, and experts from different fields are now discussing the wide-ranging impact and future possibilities of this work.